VEEV Veeva Systems Inc

Veeva Systems develops cloud software for the global life sciences industry, including CRM, regulatory content management, and clinical data solutions. Sector: Technology.

Veeva Systems Inc (VEEV) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Through the lens of capital efficiency, ROIC is 73.45%, WACC is 11.22%, and the economic spread is 62.23%. On balance, reinvested capital is working exceptionally hard, with operating returns clearing the funding cost hurdle by a wide margin. Supporting metrics show ROE at 13.87% and ROA at 9.28%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

From a market pricing perspective, trailing P/E of 32.07, forward P/E of 19.71, PEG of 1.24. The trailing-forward gap is pronounced, pointing to a company where near-term earnings estimates are running materially ahead of reported earnings. The PEG ratio suggests the market may be underpricing the company's growth trajectory relative to its current multiple. The company's weighted current ratio of 4.89 signals strong near-term financial resilience. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

The margin profile breaks down as follows: gross margin sits at 75.53%, operating margin at 29.16%, and free cash flow margin at 43.83%. The company's gross margin reflects businesses that retain a large share of revenue before overhead — a sign of genuine competitive insulation. Operating margins are solid, reflecting adequate cost control relative to the revenue base. FCF margins at this level reflect businesses that fund growth entirely from internal resources, with significant cash left over. The full margin stack is constructive, with pricing power, operating leverage, and cash conversion largely aligned.

The growth and outlook picture reads as follows: TTM revenue growth of 15.96% pointing to reasonable revenue execution across the company. In parallel, analyst consensus projects significant upside from current levels based on current consensus targets. The gap between trailing fundamentals and forward expectations matters most at inflection points — and the current environment is not without those. For long-term holders, the central question is whether today's execution quality is a leading indicator of what's already priced into analyst targets. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Reviewed in aggregate, this is a high-quality profile with few clear structural weaknesses — a combination that historically tends to support above-average long-term outcomes.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.